Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma.
Int J Mol Sci. 2022 Sep 8;23(18):10378. doi: 10.3390/ijms231810378.
Int J Mol Sci. 2022.
PMID: 36142303
Free PMC article.
Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.
Kim Y, Yun HJ, Choi KH, Kim CW, Lee JH, Weicker R, Kim SM, Park KC.
Kim Y, et al. Among authors: weicker r.
Int J Mol Sci. 2023 Nov 16;24(22):16413. doi: 10.3390/ijms242216413.
Int J Mol Sci. 2023.
PMID: 38003602
Free PMC article.
Item in Clipboard
Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma.
Lim JH, Park K, Choi KH, Kim CW, Lee JH, Weicker R, Pan CH, Kim SM, Park KC.
Lim JH, et al. Among authors: weicker r.
Int J Mol Sci. 2022 Jul 19;23(14):7971. doi: 10.3390/ijms23147971.
Int J Mol Sci. 2022.
PMID: 35887321
Free PMC article.
Item in Clipboard
Cite
Cite